Friday, November 13, 2020 1:24:57 PM
Another little something to chew on... a listing of current trials underway for this disease shows only Bluebird Bio as currently having phase 2 and 3. Now, it’s been rumored that nphc has a jv project with an as yet, unnamed partner... could it be blue bird? Who knows... we don’t have any recent filings! Lol.. blue bird has the financial clout to initiate trials where as nphc probably wouldn’t. Just a thought..
If they are not working with you..... They are working against you...
Recent NPHC News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/06/2026 09:10:21 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/25/2026 06:38:35 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/11/2026 07:22:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/17/2026 07:11:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 01/02/2026 06:52:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/23/2025 06:15:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/17/2025 10:08:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 11/24/2025 06:48:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/28/2025 08:02:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/23/2025 05:43:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/16/2025 08:38:46 PM
